Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Disease Therapeutic Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Asthma
1.2.3 Chronic Obstructive Pulmonary Disease (COPD)
1.2.4 Lung Cancer
1.2.5 Other
1.3 Market by Application
1.3.1 Global Lung Disease Therapeutic Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung Disease Therapeutic Market Perspective (2018-2033)
2.2 Lung Disease Therapeutic Growth Trends by Region
2.2.1 Global Lung Disease Therapeutic Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Lung Disease Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Lung Disease Therapeutic Forecasted Market Size by Region (2024-2033)
2.3 Lung Disease Therapeutic Market Dynamics
2.3.1 Lung Disease Therapeutic Industry Trends
2.3.2 Lung Disease Therapeutic Market Drivers
2.3.3 Lung Disease Therapeutic Market Challenges
2.3.4 Lung Disease Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Disease Therapeutic Players by Revenue
3.1.1 Global Top Lung Disease Therapeutic Players by Revenue (2018-2023)
3.1.2 Global Lung Disease Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Lung Disease Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Lung Disease Therapeutic Revenue
3.4 Global Lung Disease Therapeutic Market Concentration Ratio
3.4.1 Global Lung Disease Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Disease Therapeutic Revenue in 2022
3.5 Lung Disease Therapeutic Key Players Head office and Area Served
3.6 Key Players Lung Disease Therapeutic Product Solution and Service
3.7 Date of Enter into Lung Disease Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Disease Therapeutic Breakdown Data by Type
4.1 Global Lung Disease Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Lung Disease Therapeutic Forecasted Market Size by Type (2024-2033)
5 Lung Disease Therapeutic Breakdown Data by Application
5.1 Global Lung Disease Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Lung Disease Therapeutic Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Lung Disease Therapeutic Market Size (2018-2033)
6.2 North America Lung Disease Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Lung Disease Therapeutic Market Size by Country (2018-2023)
6.4 North America Lung Disease Therapeutic Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lung Disease Therapeutic Market Size (2018-2033)
7.2 Europe Lung Disease Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Lung Disease Therapeutic Market Size by Country (2018-2023)
7.4 Europe Lung Disease Therapeutic Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lung Disease Therapeutic Market Size (2018-2033)
8.2 Asia-Pacific Lung Disease Therapeutic Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Lung Disease Therapeutic Market Size by Region (2018-2023)
8.4 Asia-Pacific Lung Disease Therapeutic Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lung Disease Therapeutic Market Size (2018-2033)
9.2 Latin America Lung Disease Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Lung Disease Therapeutic Market Size by Country (2018-2023)
9.4 Latin America Lung Disease Therapeutic Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Disease Therapeutic Market Size (2018-2033)
10.2 Middle East & Africa Lung Disease Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Lung Disease Therapeutic Market Size by Country (2018-2023)
10.4 Middle East & Africa Lung Disease Therapeutic Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Detail
11.1.2 GSK Business Overview
11.1.3 GSK Lung Disease Therapeutic Introduction
11.1.4 GSK Revenue in Lung Disease Therapeutic Business (2018-2023)
11.1.5 GSK Recent Development
11.2 AstraZeneca
11.2.1 AstraZeneca Company Detail
11.2.2 AstraZeneca Business Overview
11.2.3 AstraZeneca Lung Disease Therapeutic Introduction
11.2.4 AstraZeneca Revenue in Lung Disease Therapeutic Business (2018-2023)
11.2.5 AstraZeneca Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim Lung Disease Therapeutic Introduction
11.3.4 Boehringer Ingelheim Revenue in Lung Disease Therapeutic Business (2018-2023)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Novartis
11.4.1 Novartis Company Detail
11.4.2 Novartis Business Overview
11.4.3 Novartis Lung Disease Therapeutic Introduction
11.4.4 Novartis Revenue in Lung Disease Therapeutic Business (2018-2023)
11.4.5 Novartis Recent Development
11.5 Mylan
11.5.1 Mylan Company Detail
11.5.2 Mylan Business Overview
11.5.3 Mylan Lung Disease Therapeutic Introduction
11.5.4 Mylan Revenue in Lung Disease Therapeutic Business (2018-2023)
11.5.5 Mylan Recent Development
11.6 Vertex Pharmaceuticals
11.6.1 Vertex Pharmaceuticals Company Detail
11.6.2 Vertex Pharmaceuticals Business Overview
11.6.3 Vertex Pharmaceuticals Lung Disease Therapeutic Introduction
11.6.4 Vertex Pharmaceuticals Revenue in Lung Disease Therapeutic Business (2018-2023)
11.6.5 Vertex Pharmaceuticals Recent Development
11.7 F. Hoffman La Roche
11.7.1 F. Hoffman La Roche Company Detail
11.7.2 F. Hoffman La Roche Business Overview
11.7.3 F. Hoffman La Roche Lung Disease Therapeutic Introduction
11.7.4 F. Hoffman La Roche Revenue in Lung Disease Therapeutic Business (2018-2023)
11.7.5 F. Hoffman La Roche Recent Development
11.8 Teva Pharmaceuticals
11.8.1 Teva Pharmaceuticals Company Detail
11.8.2 Teva Pharmaceuticals Business Overview
11.8.3 Teva Pharmaceuticals Lung Disease Therapeutic Introduction
11.8.4 Teva Pharmaceuticals Revenue in Lung Disease Therapeutic Business (2018-2023)
11.8.5 Teva Pharmaceuticals Recent Development
11.9 Cipla
11.9.1 Cipla Company Detail
11.9.2 Cipla Business Overview
11.9.3 Cipla Lung Disease Therapeutic Introduction
11.9.4 Cipla Revenue in Lung Disease Therapeutic Business (2018-2023)
11.9.5 Cipla Recent Development
11.10 Fibrogen
11.10.1 Fibrogen Company Detail
11.10.2 Fibrogen Business Overview
11.10.3 Fibrogen Lung Disease Therapeutic Introduction
11.10.4 Fibrogen Revenue in Lung Disease Therapeutic Business (2018-2023)
11.10.5 Fibrogen Recent Development
11.11 Liminal Biosciences
11.11.1 Liminal Biosciences Company Detail
11.11.2 Liminal Biosciences Business Overview
11.11.3 Liminal Biosciences Lung Disease Therapeutic Introduction
11.11.4 Liminal Biosciences Revenue in Lung Disease Therapeutic Business (2018-2023)
11.11.5 Liminal Biosciences Recent Development
11.12 PharmAkea Therapeutics
11.12.1 PharmAkea Therapeutics Company Detail
11.12.2 PharmAkea Therapeutics Business Overview
11.12.3 PharmAkea Therapeutics Lung Disease Therapeutic Introduction
11.12.4 PharmAkea Therapeutics Revenue in Lung Disease Therapeutic Business (2018-2023)
11.12.5 PharmAkea Therapeutics Recent Development
11.13 IQVIA
11.13.1 IQVIA Company Detail
11.13.2 IQVIA Business Overview
11.13.3 IQVIA Lung Disease Therapeutic Introduction
11.13.4 IQVIA Revenue in Lung Disease Therapeutic Business (2018-2023)
11.13.5 IQVIA Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Lung Disease Therapeutic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Asthma
Table 3. Key Players of Chronic Obstructive Pulmonary Disease (COPD)
Table 4. Key Players of Lung Cancer
Table 5. Key Players of Other
Table 6. Global Lung Disease Therapeutic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 7. Global Lung Disease Therapeutic Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Lung Disease Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 9. Global Lung Disease Therapeutic Market Share by Region (2018-2023)
Table 10. Global Lung Disease Therapeutic Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 11. Global Lung Disease Therapeutic Market Share by Region (2024-2033)
Table 12. Lung Disease Therapeutic Market Trends
Table 13. Lung Disease Therapeutic Market Drivers
Table 14. Lung Disease Therapeutic Market Challenges
Table 15. Lung Disease Therapeutic Market Restraints
Table 16. Global Lung Disease Therapeutic Revenue by Players (2018-2023) & (US$ Million)
Table 17. Global Lung Disease Therapeutic Market Share by Players (2018-2023)
Table 18. Global Top Lung Disease Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Disease Therapeutic as of 2022)
Table 19. Ranking of Global Top Lung Disease Therapeutic Companies by Revenue (US$ Million) in 2022
Table 20. Global 5 Largest Players Market Share by Lung Disease Therapeutic Revenue (CR5 and HHI) & (2018-2023)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Lung Disease Therapeutic Product Solution and Service
Table 23. Date of Enter into Lung Disease Therapeutic Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lung Disease Therapeutic Market Size by Type (2018-2023) & (US$ Million)
Table 26. Global Lung Disease Therapeutic Revenue Market Share by Type (2018-2023)
Table 27. Global Lung Disease Therapeutic Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 28. Global Lung Disease Therapeutic Revenue Market Share by Type (2024-2033)
Table 29. Global Lung Disease Therapeutic Market Size by Application (2018-2023) & (US$ Million)
Table 30. Global Lung Disease Therapeutic Revenue Market Share by Application (2018-2023)
Table 31. Global Lung Disease Therapeutic Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 32. Global Lung Disease Therapeutic Revenue Market Share by Application (2024-2033)
Table 33. North America Lung Disease Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 34. North America Lung Disease Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 35. North America Lung Disease Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 36. Europe Lung Disease Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 37. Europe Lung Disease Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 38. Europe Lung Disease Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 39. Asia-Pacific Lung Disease Therapeutic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 40. Asia-Pacific Lung Disease Therapeutic Market Size by Region (2018-2023) & (US$ Million)
Table 41. Asia-Pacific Lung Disease Therapeutic Market Size by Region (2024-2033) & (US$ Million)
Table 42. Latin America Lung Disease Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Latin America Lung Disease Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 44. Latin America Lung Disease Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 45. Middle East & Africa Lung Disease Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 46. Middle East & Africa Lung Disease Therapeutic Market Size by Country (2018-2023) & (US$ Million)
Table 47. Middle East & Africa Lung Disease Therapeutic Market Size by Country (2024-2033) & (US$ Million)
Table 48. GSK Company Detail
Table 49. GSK Business Overview
Table 50. GSK Lung Disease Therapeutic Product
Table 51. GSK Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 52. GSK Recent Development
Table 53. AstraZeneca Company Detail
Table 54. AstraZeneca Business Overview
Table 55. AstraZeneca Lung Disease Therapeutic Product
Table 56. AstraZeneca Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 57. AstraZeneca Recent Development
Table 58. Boehringer Ingelheim Company Detail
Table 59. Boehringer Ingelheim Business Overview
Table 60. Boehringer Ingelheim Lung Disease Therapeutic Product
Table 61. Boehringer Ingelheim Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 62. Boehringer Ingelheim Recent Development
Table 63. Novartis Company Detail
Table 64. Novartis Business Overview
Table 65. Novartis Lung Disease Therapeutic Product
Table 66. Novartis Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 67. Novartis Recent Development
Table 68. Mylan Company Detail
Table 69. Mylan Business Overview
Table 70. Mylan Lung Disease Therapeutic Product
Table 71. Mylan Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 72. Mylan Recent Development
Table 73. Vertex Pharmaceuticals Company Detail
Table 74. Vertex Pharmaceuticals Business Overview
Table 75. Vertex Pharmaceuticals Lung Disease Therapeutic Product
Table 76. Vertex Pharmaceuticals Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 77. Vertex Pharmaceuticals Recent Development
Table 78. F. Hoffman La Roche Company Detail
Table 79. F. Hoffman La Roche Business Overview
Table 80. F. Hoffman La Roche Lung Disease Therapeutic Product
Table 81. F. Hoffman La Roche Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 82. F. Hoffman La Roche Recent Development
Table 83. Teva Pharmaceuticals Company Detail
Table 84. Teva Pharmaceuticals Business Overview
Table 85. Teva Pharmaceuticals Lung Disease Therapeutic Product
Table 86. Teva Pharmaceuticals Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 87. Teva Pharmaceuticals Recent Development
Table 88. Cipla Company Detail
Table 89. Cipla Business Overview
Table 90. Cipla Lung Disease Therapeutic Product
Table 91. Cipla Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 92. Cipla Recent Development
Table 93. Fibrogen Company Detail
Table 94. Fibrogen Business Overview
Table 95. Fibrogen Lung Disease Therapeutic Product
Table 96. Fibrogen Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 97. Fibrogen Recent Development
Table 98. Liminal Biosciences Company Detail
Table 99. Liminal Biosciences Business Overview
Table 100. Liminal Biosciences Lung Disease Therapeutic Product
Table 101. Liminal Biosciences Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 102. Liminal Biosciences Recent Development
Table 103. PharmAkea Therapeutics Company Detail
Table 104. PharmAkea Therapeutics Business Overview
Table 105. PharmAkea Therapeutics Lung Disease Therapeutic Product
Table 106. PharmAkea Therapeutics Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 107. PharmAkea Therapeutics Recent Development
Table 108. IQVIA Company Detail
Table 109. IQVIA Business Overview
Table 110. IQVIA Lung Disease Therapeutic Product
Table 111. IQVIA Revenue in Lung Disease Therapeutic Business (2018-2023) & (US$ Million)
Table 112. IQVIA Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Lung Disease Therapeutic Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Lung Disease Therapeutic Market Share by Type: 2022 VS 2033
Figure 3. Asthma Features
Figure 4. Chronic Obstructive Pulmonary Disease (COPD) Features
Figure 5. Lung Cancer Features
Figure 6. Other Features
Figure 7. Global Lung Disease Therapeutic Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 8. Global Lung Disease Therapeutic Market Share by Application: 2022 VS 2033
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Retail Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Lung Disease Therapeutic Report Years Considered
Figure 13. Global Lung Disease Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 14. Global Lung Disease Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 15. Global Lung Disease Therapeutic Market Share by Region: 2022 VS 2033
Figure 16. Global Lung Disease Therapeutic Market Share by Players in 2022
Figure 17. Global Top Lung Disease Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Disease Therapeutic as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Lung Disease Therapeutic Revenue in 2022
Figure 19. North America Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 20. North America Lung Disease Therapeutic Market Share by Country (2018-2033)
Figure 21. United States Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 22. Canada Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Europe Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Lung Disease Therapeutic Market Share by Country (2018-2033)
Figure 25. Germany Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. France Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. U.K. Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. Italy Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Russia Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Nordic Countries Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Asia-Pacific Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Lung Disease Therapeutic Market Share by Region (2018-2033)
Figure 33. China Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Japan Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. South Korea Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. Southeast Asia Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. India Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. Australia Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Latin America Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Lung Disease Therapeutic Market Share by Country (2018-2033)
Figure 41. Mexico Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 42. Brazil Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Middle East & Africa Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Lung Disease Therapeutic Market Share by Country (2018-2033)
Figure 45. Turkey Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Saudi Arabia Lung Disease Therapeutic Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. GSK Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 48. AstraZeneca Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 49. Boehringer Ingelheim Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 50. Novartis Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 51. Mylan Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 52. Vertex Pharmaceuticals Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 53. F. Hoffman La Roche Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 54. Teva Pharmaceuticals Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 55. Cipla Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 56. Fibrogen Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 57. Liminal Biosciences Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 58. PharmAkea Therapeutics Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 59. IQVIA Revenue Growth Rate in Lung Disease Therapeutic Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed